PROCEPT BioRobotics (PRCT) Competitors $52.37 -1.39 (-2.59%) As of 02:33 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRCT vs. PEN, STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, NVST, and TMDXShould you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Envista (NVST), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. PROCEPT BioRobotics vs. Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies Envista TransMedics Group Penumbra (NYSE:PEN) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking. Does the MarketBeat Community prefer PEN or PRCT? Penumbra received 790 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 69.49% of users gave PROCEPT BioRobotics an outperform vote. CompanyUnderperformOutperformPenumbraOutperform Votes83180.29% Underperform Votes20419.71%PROCEPT BioRoboticsOutperform Votes4169.49% Underperform Votes1830.51% Does the media favor PEN or PRCT? In the previous week, PROCEPT BioRobotics had 1 more articles in the media than Penumbra. MarketBeat recorded 16 mentions for PROCEPT BioRobotics and 15 mentions for Penumbra. PROCEPT BioRobotics' average media sentiment score of 1.09 beat Penumbra's score of 0.60 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 9 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, PEN or PRCT? Penumbra has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Do institutionals & insiders have more ownership in PEN or PRCT? 88.9% of Penumbra shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 5.0% of Penumbra shares are held by insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, PEN or PRCT? Penumbra has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.19B8.87$90.95M$0.34805.82PROCEPT BioRobotics$224.50M13.20-$105.90M-$1.76-30.72 Do analysts rate PEN or PRCT? Penumbra presently has a consensus target price of $293.80, suggesting a potential upside of 7.23%. PROCEPT BioRobotics has a consensus target price of $91.43, suggesting a potential upside of 69.09%. Given PROCEPT BioRobotics' higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Is PEN or PRCT more profitable? Penumbra has a net margin of 1.17% compared to PROCEPT BioRobotics' net margin of -50.07%. Penumbra's return on equity of 9.74% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets Penumbra1.17% 9.74% 7.35% PROCEPT BioRobotics -50.07%-38.57%-26.06% SummaryPenumbra beats PROCEPT BioRobotics on 12 of the 19 factors compared between the two stocks. Remove Ads Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRCT vs. The Competition Export to ExcelMetricPROCEPT BioRoboticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.95B$4.09B$5.35B$7.60BDividend YieldN/A39.50%5.11%4.33%P/E Ratio-27.6027.7421.7517.84Price / Sales13.2047.00378.4594.09Price / CashN/A51.0838.1534.64Price / Book9.725.846.404.01Net Income-$105.90M$67.09M$3.20B$247.31M7 Day Performance10.75%6.07%6.79%6.75%1 Month Performance-6.16%-3.45%-8.41%-6.62%1 Year Performance6.86%13.91%10.21%0.00% PROCEPT BioRobotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRCTPROCEPT BioRobotics2.3888 of 5 stars$52.37-2.6%$91.43+74.6%+6.0%$2.87B$224.50M-26.86430Positive NewsPENPenumbra3.8601 of 5 stars$263.59+0.5%$294.47+11.7%+24.5%$10.15B$1.19B775.253,900Analyst ForecastShort Interest ↑Gap DownSTVNStevanato Group1.7165 of 5 stars€19.23+1.1%N/A-24.1%$5.82B$1.10B40.914,650Positive NewsGap DownGKOSGlaukos4.5783 of 5 stars$85.87+2.7%$163.25+90.1%-5.3%$4.86B$383.48M-29.92780Analyst ForecastHigh Trading VolumeNARIInari Medical0.3478 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6451 of 5 stars$149.72+5.5%$226.70+51.4%-35.4%$4.46B$802.80M86.541,246Analyst ForecastPositive NewsGap DownBLCOBausch + Lomb3.8726 of 5 stars$11.86-2.1%$18.82+58.7%-14.0%$4.18B$4.79B-13.0312,500Gap DownSLNOSoleno Therapeutics4.7928 of 5 stars$69.64+3.2%$99.63+43.1%+88.5%$3.19BN/A-20.9830Analyst ForecastGap DownHigh Trading VolumeIRTCiRhythm Technologies0.8901 of 5 stars$100.17-0.2%$119.73+19.5%-8.8%$3.15B$591.84M-27.521,790Positive NewsNVSTEnvista4.3983 of 5 stars$15.27-1.4%$20.18+32.2%-18.5%$2.63B$2.51B-2.3512,700Analyst RevisionNews CoveragePositive NewsGap DownTMDXTransMedics Group2.76 of 5 stars$69.15+2.2%$122.70+77.4%-5.4%$2.33B$441.54M73.56210 Remove Ads Related Companies and Tools Related Companies PEN Competitors STVN Competitors GKOS Competitors NARI Competitors INSP Competitors BLCO Competitors SLNO Competitors IRTC Competitors NVST Competitors TMDX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRCT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
